Search

Saul Ewing's Intellectual Property attorneys hosted a half-day virtual conference that addressed the following trends and challenges affecting businesses and innovators nationwide: Learning how to combat brand impersonation and cyber fraud with legal tools, cybersecurity measures, and cross-industry...

Justin Beyer brings more than 20 years of experience to his work as a litigator focusing on disputes involving trade secrets and non-compete agreements. This includes representing companies who need to protect or reacquire misappropriated information or wish to hire a competitor's former employee...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...

Irfan Malani litigates intellectual property disputes, including matters involving patents, trademarks, and trade secrets. His experience includes cases covering a wide array of technologies and industries, from telecommunications and medical devices to cybersecurity. In addition to representing...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...

Andrew Schwerin represents clients in patent and trade secret litigation on both the plaintiff and defense sides of these disputes. Outside of his litigation work, Andrew counsels clients on their IP strategy. Andrew has represented clients in connection with a range of technologies including...

Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

Alex Callo represents clients in civil litigation matters, particularly related to high-stakes intellectual property disputes (including pharmaceutical patent litigation under the Hatch-Waxman Act). Alex’s intellectual property practice touches on a range of technologies, with a focus on small...

Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...

Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...

Brian Michalek helps companies protect their technological innovations, advances and brand reputation through his intellectual property law practice. As a patent litigator, he has advised clients on a variety of disputes involving software-based technologies, wireless transactions and communications...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...